⚡︎🔋 How Our Airline Companies Are Using AI

And more: DeepL nabs $300M on a $2B valuation to focus on B2B growth

Good morning, aspiring leaders of the next-gen! ☀️

🙏🏼 Here’s what’s going on today in the AI space…

AI language translation startup DeepL has secured $300M at a $2B valuation, focusing on expanding its B2B offerings. This substantial funding underscores the high demand and potential for AI-driven language services in business settings.

Granola has introduced an AI-powered notepad designed to enhance productivity in meetings. This tool aims to streamline note-taking and information management, making meetings more efficient and actionable.

Praktika has raised $35.5M to develop AI avatars that make learning languages feel more natural. This innovative approach uses AI to simulate realistic interactions, aiming to improve language acquisition skills effectively.

Nvidia’s business continues to thrive, particularly in the AI and gaming sectors. However, market analysts suggest that regulatory challenges and supply chain issues could potentially slow its rapid growth.

EasyJet has unveiled the use of AI at its new control center in Luton, employing advanced algorithms to optimize flight operations and enhance overall efficiency. This deployment illustrates the growing adoption of AI technologies in the aviation industry.

📔 #1 Insights This Week on AI. Click the Links to Read

Remember this. Hold on to this. This is the only perfection there is, the perfection of helping others. This is the only thing we can do that has any lasting meaning. This is why we're here. To make each other feel safe.
Andre Agassi, Open

Andre Agassi is an eight-time major champion, an Olympic gold medalist, and a runner-up in seven other majors. Widely considered one of the greatest tennis players of all time, Agassi is the second of five men to achieve the career Grand Slam in the Open Era and the fifth of eight overall to make the achievement.

Here’s how AI is transforming drug discovery: AI accelerates the identification of potential drug candidates by analyzing vast datasets to predict molecule interactions more quickly and accurately. It enhances the efficiency of clinical trials through better patient selection and monitoring, reducing time and costs. Additionally, AI enables more personalized medicine by tailoring treatments to individual genetic profiles, improving therapeutic outcomes, and reducing adverse effects.

AI Is Rapidly Transforming Drug Discovery

The biopharmaceutical industry is on the brink of a revolution, with artificial intelligence (AI) emerging as a transformative force in drug development. AI's ability to reduce the time and cost of bringing new drugs to market is becoming a reality. Here’s how AI is reshaping drug development and its future potential.

AI In Target Identification And Validation

Traditionally, identifying and validating drug targets is a lengthy and often hit-and-miss process. AI, through deep learning algorithms, can analyze vast datasets, including genomic, proteomic, and clinical data, to identify potential targets more accurately and swiftly. AI platforms like AtomNet use structure-based drug design to predict how different drug molecules will interact with targets, enhancing drug development precision.

Over the next three years, AI is expected to integrate more diverse datasets, including real-world patient data, leading to even more precise target identification. This approach, potentially ranking highest in impact, speeds up drug development and increases the likelihood of clinical success, saving millions in research costs.

Accelerating Clinical Trials

AI is revolutionizing clinical trials, especially in patient recruitment and trial design. Using AI, companies can analyze electronic health records (EHRs) to identify suitable candidates more efficiently. AI algorithms can also optimize trial protocols, predicting the most effective dosing and treatment regimens. Platforms like Antidote use natural language processing to match patients to trials, significantly speeding up recruitment.

In the coming years, AI's role in adaptive trial designs will become more prominent. These designs allow for modifications to the trial as it progresses, based on interim results, which can substantially shorten trial durations. The impact here is substantial, streamlining patient recruitment and trial design to cut down years in drug development timelines.

Enhancing Drug Formulation

AI algorithms can predict compounds' solubility and stability, facilitating more efficient drug formulation. Schrödinger's AI-driven platform uses predictive modeling to optimize the molecular structure of drugs. Future advancements, like integrating quantum computing, will predict molecular behavior more accurately, further reducing formulation time. This aspect, while important, ranks third in overall impact as it refines existing processes rather than revolutionizing them.

Streamlining Regulatory Approval

AI can help navigate the complex regulatory landscape by analyzing historical data on regulatory decisions, forecasting potential hurdles, and suggesting optimal pathways for approval. AI's capability to predict regulatory outcomes will likely become more nuanced, potentially shortening the regulatory review process with precise, data-backed submissions. This area is emerging with a growing impact, ensuring a smoother, more predictable regulatory process, crucial for timely market entry.

Conclusion

The integration of AI into drug development heralds a new era in biopharma. Each of the above areas contributes differently to reducing time and costs, collectively signifying a seismic shift in drug development. In the next three years, we can anticipate a more streamlined, efficient, and cost-effective drug development process, leading to faster access to life-saving drugs for patients worldwide. This is not just an evolution; it is a revolution in healthcare powered by AI.

🛸 Let’s Teleport in The Future 🛸

AI simulates human intelligence through machines that learn from experience and imitate human thinking. It includes technologies enabling computers to analyze data, understand language, and make recommendations.

We know large language models will continue to dominate, and regulators will grow bolder. AI's issues—bias, copyright, and doomerism—will shape agendas for researchers, regulators, and the public for years. Instead, we've identified specific trends to watch in 2024.

In 2024, tech companies like Google and OpenAI will focus on user-friendly platforms that let anyone create customized chatbots without coding. These platforms enable users to develop mini chatbots tailored to specific needs. Generative AI, with tools like GPT-4 and Gemini, is becoming accessible to non-tech users, allowing them to create AI apps that process text, images, and videos.

For instance, a real estate agent can fine-tune a model to generate property descriptions from text, photos, and videos. However, the success of these tools depends on their reliability. Current challenges include inaccuracies, biases, and security vulnerabilities. Companies must address these issues to maintain user interest and trust.

Generative AI’s Second Wave: Video

In 2022, generative models like OpenAI's DALL-E and Stability AI's Stable Diffusion brought photorealistic images into the mainstream. While these tools amazed with their creations, they also raised concerns, such as knock-off art and stereotypes.

The next big leap is text-to-video. This technology will amplify the successes and challenges of text-to-image generation. Initially, models produced short, jerky clips by stitching images together. However, advancements have been swift. Runway, the startup behind Stable Diffusion, releases new generative video tools frequently. Their latest model, Gen-2, generates high-quality video clips that rival professional animation.

Continuing in tomorrow's issue…….

ChatGPT Prompting

SEO Prompts for more semantically relevant + target words & phrases people use that aren’t missing.

Keyword phrase: best drone for beginners

Example:

List 20 common ways people refer to a "drone"

(Review the list to find ones the article is missing & sprinkle in the ones that make sense to use)

List 20 common words and phrases people use to describe someone who's a "beginner" 

(Sprinkle in the missing ones in your blog post)

List 20 common ways people refer to someone who's a "beginner at flying a drone" 

And here is a prompt that is very dependent on the specific keyword phrase. But for this example, it’s:

List 20 ways a beginner at flying a drone may describe a drone and being a beginner at it

The number one site on Google will include most of the words from this list. using ChatGPT to add other words and phrases people use to find our content is a quick and easy way to boost rankings & capture more traffic from Google.

Hands-on: How to Supercharge with AI Tools

Work smarter, not harder!

I hope you find these resources helpful. Let me know if you have any questions, if there's anything else I can do to assist you, or what you would like to learn more about in AI.

Have an amazing day!

No more playing catch-up. It's time to GET AHEAD!!! 🚀🚀🚀

🙌🏼

Elena

⚡︎🔋 The Supercharged - loved by thousands of readers ❤️🙋‍♀️

Start an awesome newsletter like this one here.

The Supercharged is the #1 AI Newsletter for Entrepreneurs with 10,000 + readers working at the world’s leading startups and enterprises. The Supercharged is free for the readers. Main ads are typically sold out 2 weeks in advance. You can book future ad spots here.

Here's the Disclaimer: None of what I share is financial advice. This newsletter is for convenience and educational purposes only and is not investment advice or a solicitation to buy or sell any NFTs, Crypto, AI, or anything else. Please do your research and consult with a pro. ?

Reply

or to participate.